BridgeMD
New treatment option for Breast Cancer, Metastatic
Official title Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
ClinicalTrials.gov ID: NCT06807502
What this study is testing
- What it's testing
- Liquid biopsy is a noninvasive method for detecting and quantifying circulating tumor cells (CTCs). Thanks to ScreenCell technology, this study aims to evaluate the evolution of the number of CTCs during breast cancer follow-up.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- For all participants :
- Female with age greater than or equal to 18 years For participants with metastatic breast cancer: \- Patient observed with metastatic breast cancer...
- Participant free of any cancer at the time of inclusion, confirmed using a mammogram whose results must be satisfactory, done at the latest two years...
- Participant with no history of cancer
You likely can't join if
- For all participants:
- Male
- Age less than 18 years old
- Refusal to participate or withdrawal of consent
- Pregnant and/or breastfeeding women
- Discovery of a cancerous pathology (other than breast cancer for patients) during participant follow-up. For healthy volunteers:
See the full eligibility criteria
- For all participants :
- Female with age greater than or equal to 18 years For participants with metastatic breast cancer: \- Patient observed with metastatic breast cancer from the outset or metastatic fall from previously treated breast...
- Participant free of any cancer at the time of inclusion, confirmed using a mammogram whose results must be satisfactory, done at the latest two years before inclusion
- Participant with no history of cancer
- For all participants:
- Male
- Age less than 18 years old
- Refusal to participate or withdrawal of consent
- Pregnant and/or breastfeeding women
- Discovery of a cancerous pathology (other than breast cancer for patients) during participant follow-up. For healthy volunteers:
- History of cancer
- Detection of CTC (positive profile) during screening
The study team makes the final eligibility decision.
Where it's taking place
- Neuilly-sur-Seine, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Neuilly-sur-Seine, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.